Delivery Order SPE2DB22D3004-SPE2DB25FRA24

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $5,964.35. The contract is a firm fixed-price, non-set-aside delivery order with a completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. The contract has a ceiling value of $27,247.38 and a period of performance ending on June 25, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,454.89, is for the delivery of DESCOVY 200-25 MG TABLET medical product and has a completion date of May 15, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,088.27 firm fixed-price contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a prescription pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $18,793.08 and a period of performance ending on November 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,535.79 firm-fixed-price contract is for the supply of DESCOVY 200-25 MG TABLET medical products, with a completion date of May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 31, 2025. The contract has a ceiling value of $8,645.36 and an ultimate completion date of April 1, 2025. It is a firm fixed-price contract for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DESCOVY 200-25 MG TABLET UU 30S. The contract has an ultimate completion date of January 20, 2023, and a ceiling value of $7,362.57. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $12,019.76 and a period of performance through February 14, 2025. The contract has a firm fixed price pricing type and is not designated with any set-aside requirements, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of DESCOVY 200-25 MG TABLET UU 30S, a prescription medication. The contract has a ceiling value of $5,667.43 and a completion date of July 10, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FRA24
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $4,506.60 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs.

Generated 9/9/25, 12:44 PM